RESUMO
From 1978 through 1995, a sex ratio of 6.6:1 of boys to girls (N = 275) was observed for children referred to a specificity clinic for gender identity disorder. This article attempts to evaluate several hypotheses regarding the marked sex disparity in referral rates. The sexes did not differ on four demographic variables (age at referral, IQ, and parent's social class and marital status) and on five indices of general behavior problems on the Child Behavior Checklist; in addition, there was only equivocal evidence that boys with gender identity disorder had significantly poorer peer relations than girls with gender identity disorder. Although the percentage of boys and girls who met the complete DSM-III-R criteria for gender identity disorder was comparable, other measures of sex-typed behavior showed that the girls had more extreme cross-gender behavior than the boys. Coupled with external evidence that cross-gender behavior is less tolerated in boys than in girls by both peers and adults, it is concluded that social factors partly account for the sex difference in referral rates. Girls appear to require a higher threshold than boys for cross-gender behavior before they are referred for clinical assessment.
Assuntos
Identidade de Gênero , Pais/psicologia , Aceitação pelo Paciente de Cuidados de Saúde/etnologia , Encaminhamento e Consulta , Transexualidade/psicologia , Análise de Variância , Atitude Frente a Saúde/etnologia , Criança , Pré-Escolar , Comorbidade , Estudos Transversais , Feminino , Humanos , Relações Interpessoais , Masculino , Ontário/epidemiologia , Seleção de Pacientes , Grupo Associado , Índice de Gravidade de Doença , Fatores Sexuais , Percepção Social , Estereotipagem , Transexualidade/epidemiologiaAssuntos
Antígenos de Histocompatibilidade Classe I/genética , Homozigoto , Subpopulações de Linfócitos T/imunologia , Anticorpos Monoclonais , Antígenos CD/análise , Citometria de Fluxo/métodos , Fluoresceína-5-Isotiocianato , Antígenos HLA-A/genética , Antígenos HLA-B/genética , Antígenos de Histocompatibilidade Classe I/análise , Valores de ReferênciaAssuntos
Transplante de Medula Óssea , Transplante de Rim/imunologia , Reação em Cadeia da Polimerase/métodos , Quimeras de Transplante , Antígenos CD/análise , Cadáver , Antígenos HLA-DQ/análise , Antígenos HLA-DQ/biossíntese , Antígenos HLA-DR/análise , Antígenos HLA-DR/biossíntese , Cadeias HLA-DRB1 , Teste de Histocompatibilidade , Humanos , Imunofenotipagem , Terapia de Imunossupressão/métodos , Linfócitos/imunologia , Doadores de TecidosRESUMO
A new technique, the PCR-flow assay is described that has allowed for the serial identification and quantitation of discrete mononuclear cell subsets of donor (or recipient) bone marrow derived cells in cadaver kidney transplant recipients infused postoperatively with donor vertebral body bone marrow cells. With fixed permeabilized cells in flow cytometry the amplification power of the polymerase chain reaction (PCR), using fluorescent-labeled primers to identify single copy HLA class II DRbeta1 genes of either donor or recipient origin, is combined with multi-color fluorochrome-labeled CD epitope-specific monoclonal antibodies. The details of the methodology are described; these support the utility of the assay. Initial observations were made on the chimeric makeup of the peripheral blood as well as iliac crest bone marrow between six months and one year posttransplantation in recipients serially followed weekly and then monthly, concomitantly compared with a control group of stable kidney transplant recipients using similar therapeutic protocols, who did not receive cadaver bone marrow. Several findings are of note. In 14 recipients of two bone marrow infusions totalling a mean of 6.29+/-2.18x10(10) cells, donor CD34 positive (+) (immature) cells were fourteen times as numerous in peripheral blood six months postoperatively as in six recipients given half as many bone marrow cells in one infusion (averaging 3.02+/-0.5x10(10)). These donor CD34+ cells unexpectedly averaged 36+/-7% of the total (donor plus recipient) CD34+ subset counted. Moreover, iliac crest bone marrow aspirates contained an average of thirteen times this number of CD34+ cells than in the peripheral blood, supporting the notion of engraftment. Of additional interest, between six months and one year posttransplant although no donor cells could be detected in peripheral blood of the controls there was an identifiable presence of donor CD34+ cells in their iliac crest bone marrow, albeit 10-fold less than the marrow-infused patients. In the clinical follow-up, although there were three unrelated mortalities, there were no additional kidney losses with current serum creatinine concentrations averaging 1.3+/-0.06 mg/dl. In conclusion, the PCR-flow assay presents the possibility of identifying discrete subsets of donor or recipient cells that may have an immunoregulatory function.
Assuntos
Células da Medula Óssea , Transplante de Rim/patologia , Reação em Cadeia da Polimerase/métodos , Transferência Adotiva/métodos , Alelos , Antígenos CD34/análise , Células Sanguíneas/fisiologia , Medula Óssea/imunologia , Complexo CD3/análise , Cadáver , Contagem de Células , Citometria de Fluxo , Antígenos HLA-DR/genética , Cadeias HLA-DRB1 , Humanos , Subpopulações de Linfócitos/imunologia , Microscopia de Fluorescência , Fatores de Tempo , Quimeras de TransplanteAssuntos
Hepacivirus/isolamento & purificação , Hepatite C/diagnóstico , Transplante de Rim , Seguimentos , Hepatite C/epidemiologia , Humanos , Terapia de Imunossupressão , Transplante de Rim/imunologia , Estudos Longitudinais , Reação em Cadeia da Polimerase/métodos , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/epidemiologia , Estudos Prospectivos , Fatores de TempoRESUMO
One hundred sixty-five operative cholangiograms were attempted in 364 patients who underwent laparoscopic cholecystectomy (45%). Laparoscopic cholangiography was successful in 150 of 165 attempts (91%). Eighty-nine per cent of studies were normal (134/150) and 11% were abnormal (16/150). All 134 patients with normal cholangiograms remained asymptomatic (false-negative rate, 0%). False-positive studies occurred in 3 of 150 (2%) total cholangiograms and 3 of 12 (25%) abnormal cholangiograms consistent with choledocholithiasis. A total of 16 of 364 patients had proven common bile duct stones (4.4%). Eight of the sixteen stones were removed by preoperative endoscopic retrograde cholangiopancreatography/sphincterotomy. Five of sixteen stones were found at cholangiography, four of which were unsuspected (4/150, 2.6%). Retained common duct stones were found in 3 of 214 patients not undergoing cholangiography (1.4%). No complications or deaths occurred that were due to cholangiography. One biliary injury occurred (1/364, 0.3%), in a patient with aberrant anatomy who did not undergo cholangiography. Laparoscopic cholangiography is a safe technique with a success rate greater than 90%. Routine cholangiography is presently recommended for prevention of biliary injury, detection of stones in the cystic and common ducts, and for training purposes, especially during the learning phase of laparoscopic cholecystectomy.